Unaltered metabolism of phenytoin in thyroid disorders
- PMID: 581029
- DOI: 10.1111/j.1600-0773.1978.tb02214.x
Unaltered metabolism of phenytoin in thyroid disorders
Abstract
The metabolism of phenytoin was studied in 9 hyperthyroid and 7 hypothyroid patients before and after treatment with either antithyroid drugs or 1-thyroxine. No difference in the half-life, volume of distribution and metabolic clearance rate was found between untreated hyper- and hypothyroid subjects. Furthermore, normalisation of thyroid function test did not change the kinetic parameters of phenytoin. The results indicate that the well-known correlation between thyroid function and antipyrine kinetics cannot be extrapolated uncritically to other drugs. It is concluded that no general rules are valid in the kinetics among different drugs in thyroid pathological conditions. Each drug must be evaluated by itself in different pathological conditions.
Similar articles
-
Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.Eur J Clin Pharmacol. 1984;27(1):99-103. Eur J Clin Pharmacol. 1984. PMID: 6489432
-
Drug pharmacokinetics in thyroid dysfunction.Minerva Endocrinol. 1985 Apr-Jun;10(2):97-113. Minerva Endocrinol. 1985. PMID: 2415808 Review. No abstract available.
-
Changes in drug metabolism in children with thyroid disorders.J Clin Endocrinol Metab. 1976 Jan;42(1):155-9. doi: 10.1210/jcem-42-1-155. J Clin Endocrinol Metab. 1976. PMID: 1249184
-
Influence of thyroid status on plasma half-life of antipyrine in man.N Engl J Med. 1974 May 9;290(19):1040-2. doi: 10.1056/NEJM197405092901902. N Engl J Med. 1974. PMID: 4821905 No abstract available.
-
Endocrinology Update: Thyroid Disorders.FP Essent. 2016 Dec;451:11-16. FP Essent. 2016. PMID: 27936530 Review.
Cited by
-
Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.Br J Clin Pharmacol. 1990 Nov;30(5):737-42. doi: 10.1111/j.1365-2125.1990.tb03844.x. Br J Clin Pharmacol. 1990. PMID: 2271373 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.Eur J Clin Pharmacol. 1981 Feb;19(3):197-203. doi: 10.1007/BF00561949. Eur J Clin Pharmacol. 1981. PMID: 6894282
-
Influence of thyroid dysfunction on drug pharmacokinetics.Clin Pharmacokinet. 1981 Jul-Aug;6(4):275-97. doi: 10.2165/00003088-198106040-00003. Clin Pharmacokinet. 1981. PMID: 6166422 Review. No abstract available.
-
Oxazepam pharmacokinetics in thyroid disease.Br J Clin Pharmacol. 1984 Jan;17(1):49-53. doi: 10.1111/j.1365-2125.1984.tb04998.x. Br J Clin Pharmacol. 1984. PMID: 6419761 Free PMC article.
-
Clinical pharmacokinetics of antithyroid drugs.Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001. Clin Pharmacokinet. 1981. PMID: 6172233 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources